These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 26100457
1. Outcome and treatment of elderly patients with ANCA-associated vasculitis. Weiner M, Goh SM, Mohammad AJ, Hruskova Z, Tanna A, Bruchfeld A, Selga D, Chocova Z, Westman K, Eriksson P, Pusey CD, Tesar V, Salama AD, Segelmark M. Clin J Am Soc Nephrol; 2015 Jul 07; 10(7):1128-35. PubMed ID: 26100457 [Abstract] [Full Text] [Related]
2. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry. Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ. Am J Kidney Dis; 2015 Oct 07; 66(4):613-20. PubMed ID: 25975963 [Abstract] [Full Text] [Related]
3. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR, European Vasculitis Society (EUVAS). Ann Rheum Dis; 2015 Jun 07; 74(6):1178-82. PubMed ID: 25739829 [Abstract] [Full Text] [Related]
6. Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis. Kauffmann M, Bobot M, Robert T, Burtey S, Couvrat-Desvergnes G, Lavainne F, Puéchal X, Terrier B, Quéméneur T, Faguer S, Karras A, Brunet P, Couchoud C, Jourde-Chiche N, REIN registry and the French Vasculitis Study Group. Clin J Am Soc Nephrol; 2021 Nov 07; 16(11):1665-1675. PubMed ID: 34750159 [Abstract] [Full Text] [Related]
10. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data. de Joode AAE, Sanders JSF, Puéchal X, Guillevin LP, Hiemstra TF, Flossmann O, Rasmussen N, Westman K, Jayne DR, Stegeman CA. Rheumatology (Oxford); 2017 Nov 01; 56(11):1894-1901. PubMed ID: 28977502 [Abstract] [Full Text] [Related]
11. Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. Furuta S, Chaudhry AN, Hamano Y, Fujimoto S, Nagafuchi H, Makino H, Matsuo S, Ozaki S, Endo T, Muso E, Ito C, Kusano E, Yamagata M, Ikeda K, Kashiwakuma D, Iwamoto I, Westman K, Jayne D. J Rheumatol; 2014 Feb 01; 41(2):325-33. PubMed ID: 24429174 [Abstract] [Full Text] [Related]
12. Impact of renal involvement on survival in ANCA-associated vasculitis. Rathi M, Pinto B, Dhooria A, Sagar V, Mittal T, Rajan R, Dhir V, Kumar S, Sharma K, Nada R, Singh S, Minz RW, Sharma A. Int Urol Nephrol; 2016 Sep 01; 48(9):1477-82. PubMed ID: 27272254 [Abstract] [Full Text] [Related]
13. The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre. Mun CH, Yoo J, Jung SM, Song JJ, Park YB, Lee SW. Clin Exp Rheumatol; 2018 Sep 01; 36 Suppl 111(2):65-72. PubMed ID: 29465370 [Abstract] [Full Text] [Related]
14. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study. Sada KE, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, Fujimoto S, Muso E, Murakawa Y, Arimura Y, Makino H, Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan. Arthritis Res Ther; 2015 Nov 02; 17():305. PubMed ID: 26525413 [Abstract] [Full Text] [Related]
15. Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Höglund P, Jayne D, Mahr A, Westman K, Luqmani R. Ann Rheum Dis; 2015 Jan 02; 74(1):177-84. PubMed ID: 24243925 [Abstract] [Full Text] [Related]
16. L39. Fulminant ANCA vasculitis. Karras A, Jacquot C, Thervet E. Presse Med; 2013 Apr 02; 42(4 Pt 2):607-9. PubMed ID: 23453211 [No Abstract] [Full Text] [Related]
17. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab. Shah S, Hruskova Z, Segelmark M, Morgan MD, Hogan J, Lee SK, Dale J, Harper L, Tesar V, Jayne DR, Geetha D. Am J Nephrol; 2015 Apr 02; 41(4-5):296-301. PubMed ID: 26044574 [Abstract] [Full Text] [Related]
18. Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis. Kitagawa K, Furuichi K, Sagara A, Shinozaki Y, Kitajima S, Toyama T, Hara A, Iwata Y, Sakai N, Shimizu M, Kaneko S, Wada T, Kanazawa Study Group for Renal Diseases and Hypertension. Clin Exp Nephrol; 2016 Oct 02; 20(5):703-711. PubMed ID: 26590051 [Abstract] [Full Text] [Related]
19. Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea. Lee SW, Yu MY, Baek SH, Ahn SY, Kim S, Na KY, Chae DW, Chin HJ. J Korean Med Sci; 2016 Apr 02; 31(4):542-6. PubMed ID: 27051237 [Abstract] [Full Text] [Related]
20. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties. Prescrire Int; 2015 Jun 02; 24(161):145-8. PubMed ID: 26436161 [Abstract] [Full Text] [Related] Page: [Next] [New Search]